This Week in Nature

A news story examines the fate of using surrogate biomarkers in clinical trials. So far, reliance on markers that don't necessarily correlate with a disease itself has helped "fast-track" many drugs through the FDA approval process. Surprising findings about drugs, like GSK's Avandia, have people questioning dependence on these kinds of markers.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

A fire at a Manchester hospital may have destroyed lab equipment and data, the Guardian reports.

Researchers generate a genetic database from skeletal remains from the 1845 Franklin Expedition to the Arctic, Live Science reports.

Researchers in China have begun another trial using CRISPR/Cas9 approaches in cancer patients, according to the Wall Street Journal.

In Science this week: human DNA found in sediments from archeological sites lacking bones, and more.